Targeting autophagy in disease: established and new strategies

References

• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018 Jun;19(6):349–364.
   PubMed Web of Science ®Google Scholar
• He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Ann Rev Genet. 2009;43(1):67–93.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Koo JK, Choi AM. Molecular regulation of autophagy and its implications for metabolic diseases. Curr Opin Clin Nutr Metab Care. 2014 Jul;17(4):329–337.
   PubMed Web of Science ®Google Scholar
• Sridharan S, Jain K, Basu A. Regulation of autophagy by kinases. Cancers (Basel). 2011 Jun 9; 3(2):2630–2654.
   PubMedGoogle Scholar
• Proikas-Cezanne T, Takacs Z, Donnes P, et al. WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome. J Cell Sci. 2015 Jan 15 128;(2)207–217.
   PubMed Web of Science ®Google Scholar
• Kaufmann A, Wollert T. Scaffolding the expansion of autophagosomes. Autophagy. 2014 Jul;10(7):1343–1345.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Noda NN. Autophagy-regulating protease Atg4: structure, function, regulation and inhibition. J Antibiot (Tokyo). 2017 Sep 13.
   Web of Science ®Google Scholar
• Grunwald DS, Otto NM, Park JM, et al. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction. Autophagy. 2020 Apr 16;(4)600–614.
   PubMed Web of Science ®Google Scholar
• Birgisdottir AB, Mouilleron S, Bhujabal Z, et al. Members of the autophagy class III phosphatidylinositol 3-kinase complex I interact with GABARAP and GABARAPL1 via LIR motifs. Autophagy. 2019 Aug 15;(8)1333–1355.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Rogov VVA. Diversity of selective autophagy receptors determines the specificity of the autophagy pathway. Mol Cell. 2019 Sep; 76(2):21.
   Web of Science ®Google Scholar
• Lorincz P, Juhasz G. Autophagosome-Lysosome Fusion. J Mol Biol. 2020 Apr 3;432(8):2462–2482.
   PubMed Web of Science ®Google Scholar
• Kast DJ, Dominguez R. The cytoskeleton-autophagy connection. Curr Biol. 2017 Apr 24; 27(8):R318–R326.
   PubMed Web of Science ®Google Scholar
• Yim WW, Mizushima N. Lysosome biology in autophagy. Cell Discov. 2020; 6(1):6.
   PubMed Web of Science ®Google Scholar
• Conway O, Akpinar HA, Rogov VV, et al. Selective autophagy receptors in neuronal health and disease. J Mol Biol. 2020 Apr 3 432;(8)2483–2509.
   PubMed Web of Science ®Google Scholar
• Gatica D, Chiong M, Lavandero S, et al. Molecular mechanisms of autophagy in the cardiovascular system. Circ Res. 2015 Jan 30 116;(3)456–467.
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013 Oct;13(10):722–737.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discovery. 2019 Sep;9(9):1167–1181.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017 Mar 8;93(5):1015–1034.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Bento CF, Deretic V. Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J Exp Med. 2015 Jun 29; 212(7):979–990.
   PubMed Web of Science ®Google Scholar
• Tang H, Sebti S, Titone R, et al. Decreased BECN1 mRNA expression in human breast cancer is associated with estrogen receptor-negative subtypes and poor prognosis. EBioMedicine. 2015 Mar 2;(3)255–263.
   PubMed Web of Science ®Google Scholar
• Delaney JR, Patel CB, Bapat J, et al. Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors. PLoS Genet. 2020 Jan;16(1):e1008558.
   PubMed Web of Science ®Google Scholar
• Cuomo F, Altucci L, Cobellis G. Autophagy function and dysfunction: potential drugs as anti-cancer therapy. Cancers (Basel). 2019 Sep 29; 11(10):1465.
   PubMed Web of Science ®Google Scholar
• Kang MR, Kim MS, Oh JE, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009 Apr 217;(5)702–706.
   PubMed Web of Science ®Google Scholar
• Wible DJ, Chao HP, Tang DG, et al. ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12-ATG5-ATG16L1 complex assembly and autophagy. Cell Discov. 2019; 5(1):42.
   PubMed Web of Science ®Google Scholar
• Saito T, Ichimura Y, Taguchi K, et al. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming. Nat Commun. 2016 Jun 27 7;(1)12030.
   PubMed Web of Science ®Google Scholar
• Kimmelman AC, White E. Autophagy and tumor metabolism. Cell Metab. 2017 May 2; 25(5):1037–1043.
   PubMed Web of Science ®Google Scholar
• Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010 May 1; 70(9):3431–3434.
   PubMed Web of Science ®Google Scholar
• Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016 Sep 1; 30(17):1913–1930.
   PubMed Web of Science ®Google Scholar
• Mainz L, Rosenfeldt MT. Autophagy and cancer - insights from mouse models. FEBS J. 2018 Mar;285(5):792–808.
   PubMed Web of Science ®Google Scholar
• Strohecker AM, White E. Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers. Cancer Discov. 2014 Jul;4(7):766–772.
   PubMed Web of Science ®Google Scholar
• Vanzo R, Bartkova J, Merchut-Maya JM, et al. Autophagy role(s) in response to oncogenes and DNA replication stress. Cell Death Differ. 2020 Mar;27(3):1134–1153.
   PubMed Web of Science ®Google Scholar
• Elliott IA, Dann AM, Xu S, et al. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Proc Natl Acad Sci U S A. 2019 Apr 2 116;(14)6842–6847.
   PubMed Web of Science ®Google Scholar
• Guo JY, Teng X, Laddha SV, et al. Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev. 2016 Aug 1 30;(15)1704–1717.
   PubMed Web of Science ®Google Scholar
• Roca-Agujetas V, De Dios C, Leston L, et al. Recent Insights into the mitochondrial role in autophagy and its regulation by oxidative stress. Oxid Med Cell Longev. 2019 2019;2019: 3809308.
   PubMed Web of Science ®Google Scholar
• Goruppi S, Clocchiatti A, Dotto GP. A role for stromal autophagy in cancer-associated fibroblast activation. Autophagy. 2019 Apr;15(4):738–739.
   PubMed Web of Science ®Google Scholar
• Lebovitz CB, Robertson AG, Goya R, et al. Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy. 2015;11(9):1668–1687.
   PubMed Web of Science ®Google Scholar
• Cassidy LD, Young ARJ, Young CNJ, et al. Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. Nat Commun. 2020 Jan 16 11;(1)307.
   PubMed Web of Science ®Google Scholar
• Jiang GM, Tan Y, Wang H, et al. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer. 2019 Jan 24 18;(1)17.
   PubMed Web of Science ®Google Scholar
• Kocaturk NM, Akkoc Y, Kig C, et al. Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 2019 Jun;15(134):116–137.
   Web of Science ®Google Scholar
• Dolgin E. Anticancer autophagy inhibitors attract ‘resurgent’ interest. Nat Rev Drug Discov. 2019 Jun;18(6):408–410.
   PubMed Web of Science ®Google Scholar
• Barbosa MC, Grosso RA, Fader CM. Hallmarks of aging: an autophagic perspective. Front Endocrinol (Lausanne). 2019 Jan 9;(9):790.
   Google Scholar
• Mei Y, Thompson MD, Cohen RA, et al. Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta. 2015 Feb;1852(2):243–251.
   PubMed Web of Science ®Google Scholar
• Corti O, Blomgren K, Poletti A, et al. Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases. J Neurochem. 2020 Aug;154(4):354–371.
   PubMed Web of Science ®Google Scholar
• Stamatakou E, Wrobel L, Hill SM, et al. Mendelian neurodegenerative disease genes involved in autophagy. Cell Discov. 2020;6(1):24.
   PubMed Web of Science ®Google Scholar
• Scrivo A, Bourdenx M, Pampliega O, et al. Selective autophagy as a potential therapeutic target for neurodegenerative disorders. Lancet Neurol. 2018 Sep;17(9):802–815.
   PubMed Web of Science ®Google Scholar
• Deng Z, Purtell K, Lachance V, et al. Autophagy receptors and neurodegenerative diseases. Trends Cell Biol. 2017 Jul;27(7):491–504.
   PubMed Web of Science ®Google Scholar
• Crews L, Spencer B, Desplats P, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One. 2010 Feb 19 5;(2)e9313.
   PubMed Web of Science ®Google Scholar
• Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008 Jun 118;(6)2190–2199.
   PubMed Web of Science ®Google Scholar
• Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci. 2012 Feb 15; 125(4):795–799.
   PubMed Web of Science ®Google Scholar
• Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron. 2015 Jan 21; 85(2):257–273.
   PubMed Web of Science ®Google Scholar
• Bang Y, Kim KS, Seol W, et al. LRRK2 interferes with aggresome formation for autophagic clearance. Mol Cell Neurosci. 2016 Sep;75:71–80.
   PubMed Web of Science ®Google Scholar
• Lee JH, Yu WH, Kumar A, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010 Jun 25 141;(7)1146–1158.
   PubMed Web of Science ®Google Scholar
• Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011 Nov 68;(11)1440–1446.
   PubMedGoogle Scholar
• Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010 May 13 465;(7295)223–226.
   PubMed Web of Science ®Google Scholar
• Kim M, Ho A, Lee JH. Autophagy and human neurodegenerative diseases-A fly’s perspective. Int J Mol Sci. 2017 Jul 23 18;(7)1596.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006 Jun 15 441;(7095)880–884.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006 Jun 15 441;(7095)885–889.
   PubMed Web of Science ®Google Scholar
• Spencer B, Potkar R, Trejo M, et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson’s and Lewy body diseases. J Neurosci. 2009 Oct 28 29;(43)13578–13588.
   PubMed Web of Science ®Google Scholar
• Decressac M, Mattsson B, Weikop P, et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A. 2013 May 7 110;(19)E1817–26.
   PubMed Web of Science ®Google Scholar
• Moscat J, Karin M, Diaz-Meco MT. p62 in Cancer: signaling adaptor beyond autophagy. Cell. 2016 Oct 20; 167(3):606–609.
   PubMed Web of Science ®Google Scholar
• Monkkonen T, Debnath J. Inflammatory signaling cascades and autophagy in cancer. Autophagy. 2018;14(2):190–198.
   PubMed Web of Science ®Google Scholar
• Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011 Mar 12;(3)222–230.
   PubMed Web of Science ®Google Scholar
• Wileman T. Autophagy as a defence against intracellular pathogens. Essays Biochem. 2013;55:153–163.
   PubMed Web of Science ®Google Scholar
• Mao K, Klionsky DJ. Xenophagy: a battlefield between host and microbe, and a possible avenue for cancer treatment. Autophagy 2017 Feb;13(2):223–224.
   PubMed Web of Science ®Google Scholar
• Huang J, Brumell JH. Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol. 2014 Feb;12(2):101–114.
   PubMed Web of Science ®Google Scholar
• Monastyrska I, Ulasli M, Rottier PJ, et al. An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy. 2013 Feb 1 9;(2)164–174.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Devhare P, Sujijantarat N, et al. Knockdown of autophagy inhibits infectious hepatitis C virus release by the exosomal pathway. J Virol. 2016 Feb 1 90;(3)1387–1396.
   PubMed Web of Science ®Google Scholar
• Reggiori F, Monastyrska I, Verheije MH, et al. Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe. 2010 Jun 25 7;(6)500–508.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Thackray LB, Miller BC, et al. Coronavirus replication does not require the autophagy gene ATG5. Autophagy. 2007 Nov-Dec;3(6):581–585.
   PubMed Web of Science ®Google Scholar
• Carmona-Gutierrez D, Bauer MA, Zimmermann A, et al. Digesting the crisis: autophagy and coronaviruses. Microb Cell. 2020 May 4 7;(5)119–128.
   PubMed Web of Science ®Google Scholar
• Delorme-Axford E, Klionsky DJ. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? Autophagy. 2020 Dec; 16(12):2123–2127.
   PubMed Web of Science ®Google Scholar
• Miller K, McGrath ME, Hu Z, et al. Coronavirus interactions with the cellular autophagy machinery. Autophagy. 2020 Dec;16(12):2131–2139.
   PubMed Web of Science ®Google Scholar
• Hoffmann HH, Schneider WM, Rozen-Gagnon K, et al. TMEM41B Is a Pan-flavivirus Host Factor. Cell. 2021 Jan 7 184;(1)133–148 e20.
   PubMed Web of Science ®Google Scholar
• Schneider WM, Luna JM, Hoffmann HH, et al. Genome-Scale Identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell. 2021 Jan 7 184;(1)120–132 e14.
   PubMed Web of Science ®Google Scholar
• Miao G, Zhao H, Li Y, et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev Cell. 2021 Feb 22; 56(4):427–442. e5.
   PubMed Web of Science ®Google Scholar
• Poh Z, Goh B-BG, Chang P-EJ, et al. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients. Eur J Gastroenterol Hepatol. 2015 Jun 27;(6)638–643.
   PubMed Web of Science ®Google Scholar
• Rijkaart DC, Berkhof J, Rozendaal L, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012 Jan;13(1):78–88.
   PubMed Web of Science ®Google Scholar
• Palomino-Morales RJ, Oliver J, Gomez-Garcia M, et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun. 2009 Jun 10;(4)356–364.
   PubMed Web of Science ®Google Scholar
• Ciccacci C, Perricone C, Alessandri C, et al. Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes. Lupus. 2018 Aug 27;(9)1464–1469.
   PubMed Web of Science ®Google Scholar
• Lassen KG, Kuballa P, Conway KL, et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci U S A. 2014 May 27 111;(21)7741–7746.
   PubMed Web of Science ®Google Scholar
• Migneault F, Hebert MJ. Autophagy, tissue repair, and fibrosis: a delicate balance. Matrix Biol. 2021 Jan 14.
   PubMed Web of Science ®Google Scholar
• Moulis M, Vindis C. Autophagy in metabolic age-related human diseases. Cells 2018 Sep 24; 7(10):149.
   PubMed Web of Science ®Google Scholar
• Xie Y, Li J, Kang R, et al. Interplay between lipid metabolism and autophagy. Front Cell Dev Biol. 2020;8:431.
   PubMed Web of Science ®Google Scholar
• Ebato C, Uchida T, Arakawa M, et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 2008 Oct;8(4):325–332.
   PubMed Web of Science ®Google Scholar
• Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med. 2013 Jan 19;(1)83–92.
   PubMed Web of Science ®Google Scholar
• Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature. 2009 Apr 30 458;(7242)1131–1135.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Lee SJ, Smith A, et al. Autophagy in vascular disease. Proc Am Thorac Soc. 2010 Feb;7(1):40–47.
   PubMedGoogle Scholar
• Xie M, Morales CR, Lavandero S, et al. Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol. 2011 May;26(3):216–222.
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, et al. Autophagy is required to maintain muscle mass. Cell Metab. 2009 Dec;10(6):507–515.
   PubMed Web of Science ®Google Scholar
• Schneider JL, Cuervo AM. Liver autophagy: much more than just taking out the trash. Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):187–200.
   PubMed Web of Science ®Google Scholar
• Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015 Jan;125(1):25–32.
   PubMed Web of Science ®Google Scholar
• Vakifahmetoglu-Norberg H, Xia HG, Yuan J. Pharmacologic agents targeting autophagy. J Clin Invest. 2015 Jan;125(1):5–13.
   PubMed Web of Science ®Google Scholar
• Verbaanderd C, Maes H, Schaaf MB, et al. Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience 2017;11:781.
   PubMed Web of Science ®Google Scholar
• Maycotte P, Aryal S, Cummings CT, et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012 Feb 1 8;(2)200–212.
   PubMed Web of Science ®Google Scholar
• Li J, Kim SG, Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014 Mar 4; 19(3):373–379.
   PubMed Web of Science ®Google Scholar
• Xu F, Na L, Li Y, et al. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci. 2020;10(1):54.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Bravo-San Pedro JM, Levine B, et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017 Jul;16(7):487–511.
   PubMed Web of Science ®Google Scholar
• Limpert AS, Lambert LJ, Bakas NA, et al. Autophagy in cancer: regulation by small molecules. Trends Pharmacol Sci. 2018 Dec;39(12):1021–1032.
   PubMed Web of Science ®Google Scholar
• MacDonald AS, Group RGS. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation. 2001 Jan 27; 71(2):271–280.
   PubMed Web of Science ®Google Scholar
• Waksman R, Ajani AE, Pichard AD, et al. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol. 2004 Oct 6 44;(7)1386–1392.
   PubMed Web of Science ®Google Scholar
• Barbieri F, Albertelli M, Grillo F, et al. Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies. Drug Discov Today. 2014 Apr;19(4):458–468.
   PubMed Web of Science ®Google Scholar
• Kwitkowski VE, Prowell TM, Ibrahim A, et al. FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma. Oncologist. 2010;15(4):428–435.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Ravikumar B, Floto RA, et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009 Jan;16(1):46–56.
   PubMed Web of Science ®Google Scholar
• Liu Q, Xu C, Kirubakaran S, et al. Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. Cancer Res. 2013 Apr 15 73;(8)2574–2586.
   PubMed Web of Science ®Google Scholar
• Feldman ME, Apsel B, Uotila A, et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009 Feb 10 7;(2)e38.
   PubMed Web of Science ®Google Scholar
• Janes MR, Limon JJ, So L, et al. Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med. 2010 Feb 16;(2)205–213.
   PubMed Web of Science ®Google Scholar
• Cordaro M, Paterniti I, Siracusa R, et al. KU0063794, a Dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. Mol Neurobiol. 2017 May 54;(4)2415–2427.
   PubMed Web of Science ®Google Scholar
• Zhang H, Berel D, Wang Y, et al. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models. PLoS One. 2013; 8(1):e54918.
   PubMed Web of Science ®Google Scholar
• Chresta CM, Davies BR, Hickson I, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res. 2010 Jan 1 70;(1)288–298.
   PubMed Web of Science ®Google Scholar
• Liao H, Huang Y, Guo B, et al. Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma. Am J Cancer Res. 2015;5(1):125–139.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu YR, Wang S, et al. Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo. Tumour Biol. 2016 Sep 37;(9)11743–11752.
   PubMedGoogle Scholar
• He S, Li Q, Jiang X, et al. Design of small molecule autophagy modulators: a promising druggable strategy. J Med Chem. 2018 Jun 14 61;(11)4656–4687.
   PubMed Web of Science ®Google Scholar
• Park S, Chapuis N, Bardet V, et al. PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia. 2008 Sep 22;(9)1698–1706.
   PubMed Web of Science ®Google Scholar
• Simioni C, Cani A, Martelli AM, et al. The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget. 2015 Jul 10 6;(19)17147–17160.
   PubMedGoogle Scholar
• Chang KY, Tsai SY, Wu CM, et al. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. Clin Cancer Res. 2011 Nov 15 17;(22)7116–7126.
   PubMed Web of Science ®Google Scholar
• Fan QW, Cheng C, Hackett C, et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal. 2010 Nov 9 3;(147)ra81.
   PubMed Web of Science ®Google Scholar
• Fei HR, Tian H, Zhou XL, et al. Inhibition of autophagy enhances effects of PF-04691502 on apoptosis and DNA damage of lung cancer cells. Int J Biochem Cell Biol. 2016 Sep;78:52–62.
   PubMed Web of Science ®Google Scholar
• Mallon R, Feldberg LR, Lucas J, et al. Antitumor efficacy of PKI-587, a highly potent dual PI3K/mTOR kinase inhibitor. Clin Cancer Res. 2011 May 15 17;(10)3193–3203.
   PubMed Web of Science ®Google Scholar
• Powles T, Lackner MR, Oudard S, et al. Randomized open-label phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/mammalian target of rapamycin pathway, versus everolimus in patients with metastatic renal cell carcinoma. J Clin Oncol. 2016 May 10 34;(14)1660–1668.
   PubMed Web of Science ®Google Scholar
• Fruman DA, Chiu H, Hopkins BD, et al. The PI3K pathway in human disease. Cell. 2017;170(4):605–635.
   PubMed Web of Science ®Google Scholar
• Lamoureux F, Zoubeidi A. Dual inhibition of autophagy and the AKT pathway in prostate cancer. Autophagy. 2013 Jul;9(7):1119–1120.
   PubMed Web of Science ®Google Scholar
• Jeong EH, Choi HS, Lee TG, et al. Dual Inhibition of PI3K/Akt/mTOR pathway and role of autophagy in non-small cell lung cancer cells. Tuberc Respir Dis (Seoul). 2012 Apr 72;(4)343–351.
   PubMedGoogle Scholar
• Zorea J, Prasad M, Cohen L, et al. IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer. Cell Death Dis. 2018 Sep 20 9;(10)944.
   PubMed Web of Science ®Google Scholar
• Lin J, Sampath D, Nannini MA, et al. Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models. Clin Cancer Res. 2013 Apr 1 19;(7)1760–1772.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ren X, Zhang Y, et al. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res. 2011 Apr 1 71;(7)2654–2663.
   PubMed Web of Science ®Google Scholar
• Dan HC, Ebbs A, Pasparakis M, et al. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IkappaB kinase alpha (IKKalpha). J Biol Chem. 2014 Sep 5 289;(36)25227–25240.
   PubMed Web of Science ®Google Scholar
• Wang RC, Wei Y, An Z, et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012 Nov 16 338;(6109)956–959.
   PubMed Web of Science ®Google Scholar
• Degtyarev M, De Maziere A, Orr C, et al. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol. 2008 Oct 6 183;(1)101–116.
   PubMed Web of Science ®Google Scholar
• Richardson PG, Eng C, Kolesar J, et al. Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity. Expert Opin Drug Metab Toxicol. 2012 May;8(5):623–633.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang X, Guo H, et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy. 2013 Apr 9;(4)595–603.
   PubMed Web of Science ®Google Scholar
• Jing CH, Wang L, Liu PP, et al. Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage. Neuroscience. 2012 Jun;213(213):144–153.
   PubMed Web of Science ®Google Scholar
• Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol. 1996 Apr 16;(4)1722–1733.
   PubMed Web of Science ®Google Scholar
• Gharbi SI, Zvelebil MJ, Shuttleworth SJ, et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007 May 15 404;(1)15–21.
   PubMed Web of Science ®Google Scholar
• Chude CI, Amaravadi RK. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci. 2017 Jun 16; 18(6):6.
   Web of Science ®Google Scholar
• Perera ND, Sheean RK, Lau CL, et al. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression. Autophagy. 2018;14(3):534–551.
   PubMed Web of Science ®Google Scholar
• Jang M, Park R, Kim H, et al. AMPK contributes to autophagosome maturation and lysosomal fusion. Sci Rep. 2018 Aug 23 8;(1)12637.
   PubMed Web of Science ®Google Scholar
• Cardenas C, Foskett JK. Mitochondrial Ca(2+) signals in autophagy. Cell Calcium. 2012 Jul; 52(1):44–51.
   PubMed Web of Science ®Google Scholar
• Guigas B, Viollet B. Targeting AMPK: from ancient drugs to new small-molecule activators. Exp Suppl. 2016;107:327–350.
   PubMedGoogle Scholar
• Wang Y, Xu W, Yan Z, et al. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 2018 Mar 20 37;(1)63.
   PubMed Web of Science ®Google Scholar
• Dowling RJ, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med. 2011 Apr;9(1):33.
   PubMed Web of Science ®Google Scholar
• Fontaine E. Metformin-induced mitochondrial complex I inhibition: facts, uncertainties, and consequences. Front Endocrinol (Lausanne). 2018;9:753.
   PubMed Web of Science ®Google Scholar
• Rotermund C, Machetanz G, Fitzgerald JC. The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol (Lausanne). 2018;9:400.
   PubMed Web of Science ®Google Scholar
• Saraei P, Asadi I, Kakar MA, et al. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019;11:3295–3313.
   PubMed Web of Science ®Google Scholar
• Walter C, Clemens LE, Muller AJ, et al. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro. Neuropharmacology. 2016 Sep;108:24–38.
   PubMed Web of Science ®Google Scholar
• Liu W, Mao L, Ji F, et al. Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts. Oncotarget. 2017 Feb 7 8;(6)10543–10552.
   PubMedGoogle Scholar
• Huang L, Dai K, Chen M, et al. The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy. J Cardiovasc Pharmacol Ther. 2016 Jan 21;(1)70–81.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park S, Takahashi Y, et al. The association of AMPK with ULK1 regulates autophagy. PLoS One. 2010 Nov 3 5;(11)e15394.
   PubMed Web of Science ®Google Scholar
• Robert G, Ben Sahra I, Puissant A, et al. Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death. PLoS One. 2009 Nov 18 4;(11)e7889.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 Jun;5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Pineda-Ramirez N, Alquisiras-Burgos I, Ortiz-Plata A, et al. Resveratrol activates neuronal autophagy through AMPK in the Ischemic Brain. Mol Neurobiol. 2020 Feb;57(2):1055–1069.
   PubMed Web of Science ®Google Scholar
• Redmann M, Benavides GA, Berryhill TF, et al. Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons. Redox Biol. 2017 Apr;11:73–81.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435–1455.
   PubMed Web of Science ®Google Scholar
• Ding ZB, Hui B, Shi YH, et al. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res. 2011 Oct 1 17;(19)6229–6238.
   PubMed Web of Science ®Google Scholar
• Boya P, Gonzalez-Polo RA, Poncet D, et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 2003 Jun 19 22;(25)3927–3936.
   PubMed Web of Science ®Google Scholar
• Eng CH, Wang Z, Tkach D, et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A. 2016 Jan 5 113;(1)182–187.
   PubMed Web of Science ®Google Scholar
• King MA, Ganley IG, Flemington V. Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016 Aug 25; 35(34):4518–4528.
   PubMed Web of Science ®Google Scholar
• McAfee Q, Zhang Z, Samanta A, et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci U S A. 2012 May 22 109;(21)8253–8258.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Winkler JD. Lys05: a new lysosomal autophagy inhibitor. Autophagy. 2012 Sep; 8(9):1383–1384.
   PubMed Web of Science ®Google Scholar
• Carew JS, Espitia CM, Zhao W, et al. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clin Cancer Res. 2017 Jun 1 23;(11)2869–2879.
   PubMed Web of Science ®Google Scholar
• Choi HS, Jeong EH, Lee TG, et al. Autophagy Inhibition with monensin enhances cell cycle arrest and apoptosis induced by mTOR or Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells. Tuberc Respir Dis (Seoul). 2013 Jul;75(1):9–17.
   PubMedGoogle Scholar
• Renna M, Schaffner C, Brown K, et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest. 2011 Sep;121(9):3554–3563.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Tagawa Y, Yoshimori T, et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct. 1998 Feb 23;(1)33–42.
   PubMed Web of Science ®Google Scholar
• Yang YP, Hu LF, Zheng HF, et al. Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol Sin. 2013 May;34(5):625–635.
   PubMed Web of Science ®Google Scholar
• Egan DF, Chun MG, Vamos M, et al. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. Mol Cell. 2015Jul 1659;(2)285–297.
   PubMed Web of Science ®Google Scholar
• Vahsen BF, Ribas VT, Sundermeyer J, et al. Inhibition of the autophagic protein ULK1 attenuates axonal degeneration in vitro and in vivo, enhances translation, and modulates splicing. Cell Death Differ. 2020 Oct 27;(10)2810–2827.
   PubMed Web of Science ®Google Scholar
• Petherick KJ, Conway OJ, Mpamhanga C, et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015 May 1 290;(18)11376–11383.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fu L, Zhang S, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem Sci. 2017 Apr 1 8;(4)2687–2701.
   PubMed Web of Science ®Google Scholar
• Cheong H, Lindsten T, Wu J, et al. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A. 2011 Jul 5 108;(27)11121–11126.
   PubMed Web of Science ®Google Scholar
• Liu L, Yan L, Liao N, et al. A review of ULK1-mediated autophagy in drug resistance of cancer. Cancers (Basel). 2020 Feb 4 12;(2)352.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Tremel S, Williams RL. VPS34 complexes from a structural perspective. J Lipid Res. 2019 Feb; 60(2):229–241.
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol.2010 Jun20;(6):355–62.
   Google Scholar
• Miller S, Tavshanjian B, Oleksy A, et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science. 2010 Mar 26 327;(5973)1638–1642.
   PubMed Web of Science ®Google Scholar
• Bago R, Malik N, Munson MJ, et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem J. 2014 Nov 1 463;(3)413–427.
   PubMed Web of Science ®Google Scholar
• Dowdle WE, Nyfeler B, Nagel J, et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol. 2014 Nov 16;(11)1069–1079.
   PubMed Web of Science ®Google Scholar
• Dyczynski M, Yu Y, Otrocka M, et al. Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib. Cancer Lett. 2018 Oct 28;435:32–43.
   PubMed Web of Science ®Google Scholar
• Noman MZ, Parpal S, Van Moer K, et al. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy. Sci Adv. 2020 May;6(18):eaax7881.
   PubMed Web of Science ®Google Scholar
• Ronan B, Flamand O, Vescovi L, et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol. 2014 Dec 10;(12)1013–1019.
   PubMed Web of Science ®Google Scholar
• Janji B, Hasmim M, Parpal S, et al. Firing up the cold tumors by targeting Vps34. Oncoimmunology. 2020 Aug 31 9;(1)1809936.
   PubMed Web of Science ®Google Scholar
• Liu J, Xia H, Kim M, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011 Sep 30 147;(1)223–234.
   PubMed Web of Science ®Google Scholar
• Agrotis A, On KR. ATG4B as drug target for treatment of solid tumours-the knowns and the unknowns. Cells. 2019 Dec 24;91.
   PubMed Web of Science ®Google Scholar
• Fujita N, Hayashi-Nishino M, Fukumoto H, et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell. 2008 Nov 19;(11)4651–4659.
   PubMed Web of Science ®Google Scholar
• Drag M, Salvesen GS. Emerging principles in protease-based drug discovery. Nat Rev Drug Discov. 2010 Sep;9(9):690–701.
   PubMed Web of Science ®Google Scholar
• Akin D, Wang SK, Habibzadegah-Tari P, et al. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy. 2014;10(11):2021–2035.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Kuhn B, Aebi J, et al. Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors. ACS Med Chem Lett. 2016 Aug 11 7;(8)802–806.
   PubMed Web of Science ®Google Scholar
• Xu D, Xu Z, Han L, et al. Identification of New ATG4B inhibitors based on a novel high-throughput screening platform. SLAS Discov. 2017 Apr 22;(4)338–347.
   PubMed Web of Science ®Google Scholar
• Chu J, Fu Y, Xu J, et al. ATG4B inhibitor FMK-9a induces autophagy independent on its enzyme inhibition. Arch Biochem Biophys. 2018 Apr 15;644:29–36.
   PubMed Web of Science ®Google Scholar
• Kurdi A, Cleenewerck M, Vangestel C, et al. ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice. Biochem Pharmacol. 2017 Aug 15;138:150–162.
   PubMed Web of Science ®Google Scholar
• Liu PF, Tsai KL, Hsu CJ, et al. Drug Repurposing Screening Identifies Tioconazole as an ATG4 inhibitor that suppresses autophagy and sensitizes cancer cells to chemotherapy. Theranostics. 2018;8(3):830–845.
   PubMed Web of Science ®Google Scholar
• Bosc D, Vezenkov L, Bortnik S, et al. A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B. Sci Rep. 2018 Aug 3 8;(1)11653.
   PubMed Web of Science ®Google Scholar
• Fu Y, Hong L, Xu J, et al. Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo. Autophagy. 2019 Feb 15;(2)295–311.
   PubMed Web of Science ®Google Scholar
• Huang SC, Adhikari S, Brownell JE, et al. Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors. Bioorg Med Chem. 2020 Oct 1 28;(19)115681.
   PubMed Web of Science ®Google Scholar
• Xia HG, Zhang L, Chen G, et al. Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy. 2010 Jan 6;(1)61–66.
   PubMed Web of Science ®Google Scholar
• Kania E, Pajak B, O’Prey J, et al. Verapamil treatment induces cytoprotective autophagy by modulating cellular metabolism. FEBS J. 2017 May;284(9):1370–1387.
   PubMed Web of Science ®Google Scholar
• Ochi M, Kawai Y, Tanaka Y, et al. Characterization of nicardipine hydrochloride-induced cell injury in human vascular endothelial cells. J Toxicol Sci. 2015 Feb;40(1):71–76.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Wong PM, Gammoh N, et al. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell. 2011 Jun 24 42;(6)731–743.
   PubMed Web of Science ®Google Scholar
• Sun F, Xu X, Wang X, et al. Regulation of autophagy by Ca(2). Tumour Biol. 2016 Nov 1837;(12)15467–15476.
   Google Scholar
• Martens S, Nakamura S, Yoshimori T. Phospholipids in Autophagosome Formation and Fusion. J Mol Biol. 2016 Oct 27428;(24 Pt A)4819–4827.
   Google Scholar
• Motoi Y, Shimada K, Ishiguro K, et al. Lithium and autophagy. ACS Chem Neurosci. 2014 Jun 185;(6)434–442.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Floto RA, Berger Z, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005 Sep 26 170;(7)1101–1111.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Krishna G, Imarisio S, et al. A rational mechanism for combination treatment of Huntington’s disease using lithium and rapamycin. Hum Mol Genet. 2008 Jan 15 17;(2)170–178.
   PubMed Web of Science ®Google Scholar
• Pupyshev AB, Tikhonova MA, Akopyan AA, et al. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson’s disease. Pharmacol Biochem Behav. 2019 Feb;177:1–11.
   PubMed Web of Science ®Google Scholar
• Mackeh R, Perdiz D, Lorin S, et al. Autophagy and microtubules - new story, old players. J Cell Sci.2013 Mar 1 126;(5)1071–1080.
   PubMed Web of Science ®Google Scholar
• Madeo F, Bauer MA, Carmona-Gutierrez D, et al. Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy. 2019 Jan;15(1):165–168.
   PubMed Web of Science ®Google Scholar
• Singh S, Kumar R, Garg G, et al. Spermidine, a caloric restriction mimetic, provides neuroprotection against normal and D-galactose-induced oxidative stress and apoptosis through activation of autophagy in male rats during aging. Biogerontology. 2021 Feb;22(1):35–47.
   PubMed Web of Science ®Google Scholar
• Rosenfeld MR, Ye X, Supko JG, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 2014 Aug;10(8):1359–1368.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Rubinson DA, Wang X, et al. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. The Oncologist. 2014 Jun;19(6):637–638.
   PubMed Web of Science ®Google Scholar
• Yang S, Kimmelman AC. A critical role for autophagy in pancreatic cancer. Autophagy. 2011 Aug;7(8):912–913.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011 Apr 1 25;(7)717–729.
   PubMed Web of Science ®Google Scholar
• Kinsey CG, Camolotto SA, Boespflug AM, et al. Protective autophagy elicited by RAF-->MEK-->ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med. 2019 Apr 25;(4)620–627.
   PubMed Web of Science ®Google Scholar
• Bryant KL, Stalnecker CA, Zeitouni D, et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019 Apr;25(4):628–640.
   PubMed Web of Science ®Google Scholar
• Yang MC, Wang HC, Hou YC, et al. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol Cancer. 2015 Oct;14(1):179.
   PubMed Web of Science ®Google Scholar
• Levy JM, Thorburn A. Modulation of pediatric brain tumor autophagy and chemosensitivity. J Neurooncol. 2012 Jan;106(2):281–290.
   PubMed Web of Science ®Google Scholar
• Levy JM, Thompson JC, Griesinger AM, et al. Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discov. 2014 Jul 4;(7)773–780.
   PubMed Web of Science ®Google Scholar
• Mulcahy Levy JM, Zahedi S, Griesinger AM, et al. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Elife. 2017 Jan;17:6.
   Google Scholar
• Mrakovcic M, Kleinheinz J, Frohlich LF. Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: implications for p53. Int J Mol Sci. 2017 Aug 31; 18(9):9.
   Web of Science ®Google Scholar
• Mahalingam D, Mita M, Sarantopoulos J, et al. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy. 2014 Aug;10(8):1403–1414.
   PubMed Web of Science ®Google Scholar
• Rangwala R, Chang YC, Hu J, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 2014 Aug;10(8):1391–1402.
   PubMed Web of Science ®Google Scholar
• Chi MS, Lee CY, Huang SC, et al. Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients. Oncotarget. 2015 Oct 6 6;(30)29808–29817.
   PubMedGoogle Scholar
• Masuelli L, Granato M, Benvenuto M, et al. Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice. Oncoimmunology. 2017;6(11):e1356151.
   PubMed Web of Science ®Google Scholar
• Mukubou H, Tsujimura T, Sasaki R, et al. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. Int J Oncol. 2010 Oct;37(4):821–828.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xian X, Wang Z, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018 Aug 238;(3)3.
   PubMed Web of Science ®Google Scholar
• Suresh SN, Chakravorty A, Giridharan M, et al. Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases. J Mol Biol. 2020 Apr 3 432;(8)2822–2842.
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Rubinsztein DC. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Mol Aspects Med. 2006 Oct-Dec;27(5–6):520–527.
   PubMedGoogle Scholar
• Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004 Jun;36(6):585–595.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Rapamycin GV. Alzheimer’s disease: time for a clinical trial? Sci Transl Med. 2019 Jan 23; 11(476):476.
   Web of Science ®Google Scholar
• Prasad A, Bharathi V, Sivalingam V, et al. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front Mol Neurosci. 2019;12:25.
   PubMed Web of Science ®Google Scholar
• Rose C, Menzies FM, Renna M, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington’s disease. Hum Mol Genet. 2010 Jun 1 19;(11)2144–2153.
   PubMed Web of Science ®Google Scholar
• Underwood BR, Green-Thompson ZW, Pugh PJ, et al. An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease. J Neurol. 2017 Dec;264(12):2457–2463.
   PubMed Web of Science ®Google Scholar
• Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020 Mar;19(3):271–278.
   PubMed Web of Science ®Google Scholar
• Bessi V, Mazzeo S, Padiglioni S, et al. From subjective cognitive decline to alzheimer’s disease: the predictive role of neuropsychological assessment, personality traits, and cognitive reserve. A 7-Year Follow-Up Study. J Alzheimers Dis. 2018;63(4):1523–1535.
   PubMed Web of Science ®Google Scholar
• Wirth M, Benson G, Schwarz C, et al. The effect of spermidine on memory performance in older adults at risk for dementia: a randomized controlled trial. Cortex 2018 Dec;109:181–188.
   PubMed Web of Science ®Google Scholar
• Gupta VK, Scheunemann L, Eisenberg T, et al. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci. 2013 Oct;16(10):1453–1460.
   PubMed Web of Science ®Google Scholar
• Wirth M, Schwarz C, Benson G, et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol for a randomized controlled trial. Alzheimers Res Ther. 2019 May 1 11;(1)36.
   PubMed Web of Science ®Google Scholar
• Kiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr. 2018 Aug 1108;(2)371–380.
   PubMed Web of Science ®Google Scholar
• Alves-Cruzeiro JM, Mendonca L, Pereira De Almeida L, et al. Motor dysfunctions and neuropathology in mouse models of spinocerebellar Ataxia Type 2: a comprehensive review. Front Neurosci. 2016;10:572.
   PubMed Web of Science ®Google Scholar
• Bialik S, Dasari SK, Kimchi A. Autophagy-dependent cell death - where, how and why a cell eats itself to death. J Cell Sci. 2018 Sep 20; 131(18):18.
   Web of Science ®Google Scholar
• Button RW, Luo S, Rubinsztein DC. Autophagic activity in neuronal cell death. Neurosci Bull. 2015 Aug;31(4):382–394.
   PubMed Web of Science ®Google Scholar
• Malik BR, Maddison DC, Smith GA, et al. Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain. 2019 Nov 29;12(1):100.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Yan P, Ma X, et al. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Abeta Generation and Amyloid Plaque Pathogenesis. J Neurosci. 2015 Sep 2 35;(35)12137–12151.
   PubMed Web of Science ®Google Scholar
• Arotcarena ML, Bourdenx M, Dutheil N, et al. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. JCI Insight. 2019 Aug 22 4;(16)16.
   Web of Science ®Google Scholar
• Torra A, Parent A, Cuadros T, et al. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents parkinson’s disease-related neurodegeneration. Mol Ther. 2018 Jun 6 26;(6)1552–1567.
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013 Feb 14 494;(7436)201–206.
   PubMed Web of Science ®Google Scholar
• Roy J, Paquette JS, Fortin JF, et al. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother. 2002 Nov 46;(11)3447–3455.
   PubMed Web of Science ®Google Scholar
• Nicoletti F, Lapenta C, Donati S, et al. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin. Clin Exp Immunol. 2009 Jan 155;(1)28–34.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6 383;(6)517–525.
   PubMed Web of Science ®Google Scholar
• Shojaei S, Suresh M, Klionsky DJ, et al. Autophagy and SARS-CoV-2 infection: apossible smart targeting of the autophagy pathway. Virulence. 2020 Dec 11;(1)805–810.
   PubMed Web of Science ®Google Scholar
• Nalawansha DA, Crews CM. PROTACs: an emerging therapeutic modality in precision medicine. Cell Chem Biol. 2020 Aug 20; 27(8):998–1014.
   PubMed Web of Science ®Google Scholar
• Sakamoto KM, Kim KB, Kumagai A, et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci U S A. 2001 Jul 17 98;(15)8554–8559.
   PubMed Web of Science ®Google Scholar
• Ding Y, Fei Y, Lu B. Emerging new concepts of degrader technologies. Trends Pharmacol Sci. 2020 Jul;41(7):464–474.
   PubMed Web of Science ®Google Scholar
• Bauerlein FJB, Fernandez-Busnadiego R, Baumeister W. Investigating the structure of neurotoxic protein aggregates inside cells. Trends Cell Biol. 2020 Dec;30(12):951–966.
   PubMed Web of Science ®Google Scholar
• Wolf DH, Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta. 2004 Nov 29; 1695(1–3):19–31.
   PubMed Web of Science ®Google Scholar
• Banik SM, Pedram K, Wisnovsky S, et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020 Aug;584(7820):291–297.
   PubMed Web of Science ®Google Scholar
• Takahashi D, Moriyama J, Nakamura T, et al. AUTACs: cargo-specific degraders using selective autophagy. Mol Cell. 2019 Dec 576;(5)797–810 e10.
   PubMed Web of Science ®Google Scholar
• Sawa T, Zaki MH, Okamoto T, et al. Protein S-guanylation by the biological signal 8-nitroguanosine 3ʹ,5ʹ-cyclic monophosphate. Nat Chem Biol. 2007 Nov 3;(11)727–735.
   PubMed Web of Science ®Google Scholar
• Ito C, Saito Y, Nozawa T, et al. Endogenous nitrated nucleotide is a key mediator of autophagy and innate defense against bacteria. Mol Cell. 2013 Dec 26 52;(6)794–804.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhu C, Ding Y, et al. ATTEC: a potential new approach to target proteinopathies. Autophagy. 2020 Jan;16(1):185–187.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang C, Wang Z, et al. Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds. Nature. 2019 Nov 575;(7781)203–209.
   PubMed Web of Science ®Google Scholar
• Vargas JNS, Wang C, Bunker E, et al. Spatiotemporal Control of ULK1 Activation by NDP52 and TBK1 during Selective Autophagy. Mol Cell. 2019 Apr 18 74;(2)347–362 e6.
   PubMed Web of Science ®Google Scholar
• Zachari M, Rainard JM, Pandarakalam GC, et al. The identification and characterisation of autophagy inhibitors from the published kinase inhibitor sets. Biochem J. 2020 Feb 28 477;(4)801–814.
   PubMed Web of Science ®Google Scholar
• Heckmann BL, Green DR. LC3-associated phagocytosis at a glance. J Cell Sci. 2019 Feb 20;132;(5)536:–jcs222984.
   Google Scholar
• Heckmann BL, Teubner BJW, Tummers B, et al. LC3-associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in Murine Alzheimer’s Disease. Cell. 2019 Jul 25 178;(3)536–551 e14.
   PubMed Web of Science ®Google Scholar
• Leidal AM, Huang HH, Marsh T, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020 Feb 22;(2)187–199.
   PubMed Web of Science ®Google Scholar
• Yoshii SR, Mizushima N. Monitoring and Measuring Autophagy. Int J Mol Sci. 2017 Aug 28; 18(9):1865.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021 Feb;8:1–382.
   Web of Science ®Google Scholar
• Mejlvang J, Olsvik H, Svenning S, et al. Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy. J Cell Biol. 2018 Oct 1 217;(10)3640–3655.
   PubMed Web of Science ®Google Scholar
• Zellner S, Schifferer M, Behrends C. Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling. Mol Cell. 2021 Mar; 18 81(6):1337–1354.e8.
   Google Scholar
• Sahani MH, Itakura E, Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy. 2014 Mar; 10(3):431–441.
   PubMed Web of Science ®Google Scholar
• Habisov S, Huber J, Ichimura Y, et al. Structural and functional analysis of a novel interaction motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation. J Biol Chem. 2016 Apr 22 291;(17)9025–9041.
   PubMed Web of Science ®Google Scholar
• Zatyka M, Sarkar S, Barrett T. Autophagy in rare (nonlysosomal) neurodegenerative diseases. J Mol Biol. 2020 Apr 3; 432(8):2735–2753.
   PubMed Web of Science ®Google Scholar
• Kuma A, Komatsu M, Mizushima N. Autophagy-monitoring and autophagy-deficient mice. Autophagy. 2017 Oct 3; 13(10):1619–1628.
   PubMed Web of Science ®Google Scholar
• Kim KW, Hwang M, Moretti L, et al. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy. 2008 Jul 4;(5)659–668.
   PubMed Web of Science ®Google Scholar
• Kraft C, Boya P, Codogno P, et al. Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy. Autophagy. 2019 Feb;15(2):347–351.
   PubMed Web of Science ®Google Scholar
• Hitchcock SA, Pennington LD. Structure-brain exposure relationships. J Med Chem. 2006,49; 49(26):7559–7583.
   PubMed Web of Science ®Google Scholar